Introduction
Chymases constitute a family of mast cell (MC) 1 serine proteases with chymotrypsinlike substrate specificity, i.e. they cleave a substrate at the C-terminal side of aromatic amino acids. When comparing the structures of a variety of leukocyte serine proteases, chymases form a separate branch, indicating a common ancestor for this subfamily. Based on the phylogenetic tree, chymases can be subdivided into α-and β-chymases (1). A single gene encoding an α-chymase is present in most investigated mammalian species, but genes encoding β-chymases seem to be present in rodents only. The rodent α-chymases rat mast cell protease 5 (rMCP-5) (2) (initially designated rMCP-3, (3)) and mouse mast cell protease 5 (mMCP-5) (4) are 95%
identical at the protein level and have similar expression patterns, indicating that they are functional homologues (3, 5) . mMCP-5 and rMCP-5 are predominantly expressed in connective tissue MCs, but also early in MC development (6) (7) (8) .
The substrate specificities of mMCP-5/rMCP-5 have never been studied and thus the biological function of the rodent α-chymases is unknown. In fact, neither of these chymases has been purified to allow any biochemical characterization. Instead, most data today on α-chymases originate from studies on the human chymase (HC). HC expression is restricted to a mast cell subpopulation termed MC TC , which resides primarily in submucosa and connective tissue (9) (10) (11) . Implicated substrates for human chymase include procollagenase (12) , the birch pollen protein profilin (13) and vasoactive peptides (14) . In addition, HC can convert angiotensin I into angiotensin II, a blood pressure regulator (15) (16) (17) . Their substrate-binding cleft is composed of several segments, consisting of the amino acids 189-195, 213-220 and 225-228 (chymotrypsin numbering) (18) . Conformational analysis of the 213-220 loop of seven serine proteases with trypsin-, chymotrypsin-or elastase-specificity revealed three different possible backbone structures (19) , where the enzymes having the same backbone structure of amino acids 213-220 were shown to share P1 specificity (19) . It was suggested that amino acid 216 is important to promote accurate positioning of the substrate scissile bond. A valine residue in position 216 gives a backbone conformation that leads to elastase-like specificity, whereas a Gly residue at this position leads to a chymotrypsin-like specificity. In rodent α-chymases the amino acid residue at position 216 is a Val, indicating that these enzymes, despite being classified as chymases, may actually possess elastaselike properties. In contrast, the human α-chymase has a Gly residue at this position, in agreements with the known chymotrypsin-like properties of the human counterpart.
To test the importance of the 216 amino acid residue in determining cleavage specificity, a G216V mutant of HC was recently expressed and its P1 cleavage specificity was investigated. Indeed, the catalytic properties of this mutant were elastase-like and its chymotrypsin-like activity was lost (20) .
In this study, the possibility that rodent α-chymases actually possess elastase-like properties was exploited. 
Experimental procedures
Expression and purification of recombinant rMCP-5
The cDNA for rMCP-5 (GenBank accession number U67908) was isolated as previously described (2) and the coding region for rMCP-5 was amplified by PCR.
The upstream PCR primer introduced an N-terminal His 6 -tag as well as an enterokinase-site (EK-site) consisting of the amino acids Asp-Asp-Asp-Asp-Lys, which replaced the natural activation peptide. The EK-site enables subsequent removal of the His tag as well as the peptide susceptible to enterokinase, producing the mature rMCP-5 protein. The PCR product was inserted in the pCEP-Pu2 vector (21, 22) , and the nucleotide sequence confirmed using the Thermo Sequenaseradiolabeled terminator cycle sequencing kit (Amersham Biosciences). Human embryonic kidney cells were transfected with the vector as previously described (21) .
Selection of transfected cells was initiated by addition of 1.5 µg/ml puromycin to the cell culture medium (Dulbecco's modified Eagle's medium with Glutamax-1, supplied with 5% fetal calf serum and 50 µg/ml gentamicin). After one week of selection, the puromycin concentration was decreased to 0.5 µg/ml. The conditioned medium was collected and centrifuged to remove cell debris, followed by the addition of 0.3 ml of Ni-NTA-agarose beads/liter (Qiagen) and Triton X-100 to a final concentration of 0.1%. After 45 min incubation at 4 °C with mild shaking, the beads were pelleted by centrifugation and transferred to 10-ml PolyPrep columns (Bio-Rad).
The beads were washed with PBS (pH 7.2) containing 1 M NaCl and 0.1% Tween-20
and the column was eluted with 100 mM imidazole, 0.1% Triton X-100 in PBS.
Protein purity (and approximate concentration) was checked by SDS-PAGE analysis. After incubation, the samples were separated by SDS-PAGE under reducing conditions. The gels were stained with Coomassie Brilliant Blue, incubated 1 h in 1 M Na-salicylate and dried in a vacuum dryer. Gels were then exposed to X-ray films for 48 h.
Inhibition of rMCP-5 by α 1 -antitrypsin in the presence or absence of heparin
The sensitivity of rMCP-5 to inhibition by α 1 -antitrypsin (α 1 -AT) was determined by 
Determination of cleavage specificity by phage-displayed nonapeptides
The library of phage-displayed peptides was constructed as previously described (23) .
An aliquot of the amplified phages (∼10 9 plaque forming units) were allowed to bind 9 to 100 µl Ni-NTA agarose beads for 1 h while rotating gently. Unbound phages were removed by washing five times with 1.5 ml 1 M NaCl, 0.1% Tween-20 in PBS, pH 7.2, and further washed twice in 1.5 ml PBS and finally resuspended in 270 µl PBS. A control elution of the phages with 100 µl 500 mM imidazole concluded that at least 1 x 10 8 phages were attached to the matrix after washing. rMCP-5 was digested with enterokinase as previously described, in the absence of heparin, and then subjected to heparin-Sepharose purification. Following elution with PBS containing 1.5 M NaCl, heparin was added to a 10:1 mass ratio of heparin to protease. The selection was started by adding ∼0.2 µg protease (∼27 nM final concentration), or buffer without protease as a control, to the tubes with the resuspended beads. The protease was allowed to digest susceptible phages over night with gentle agitation. To recover released phages, the supernatant was removed and the beads washed in 100 µl PBS.
To ensure that all recovered phages lacked the histidine tag, 15 µl fresh Ni-NTA agarose beads were added to the phage suspension and the mixture agitated for 15 min followed by centrifugation to recover the supernatant. Ten µl of the supernatant was used to determine the amount of detached phages in each round of selection. The remaining 290 µl of the supernatant was added to a 10-ml culture (OD= ∼0.6) of E.
Coli (BLT5615). The bacteria had been induced with 100 µl 100 mM isopropyl-1-thio-β-D-galactopyranoside (IPTG) 30 min before phage addition, to ensure production of the phage capsid protein. Following six rounds of selection, 40 plaques were arbitrarily isolated from LB plates. The oligonucleotide inserted into the phage DNA was amplified by PCR, and the randomized sequence determined by nucleic acid sequencing.
Results

Expression and purification of recombinant rMCP-5
rMCP-5 was expressed as a fusion protein containing an N-terminal His 6 -tag followed by a peptide susceptible to enterokinase, where the EK site was replacing the original propeptide of rMCP-5. Before cleavage with enterokinase, rMCP-5 migrates as a protein band of approximately 35 kDa (Fig. 1A) . Impurities can be seen at around 66 kDa, of which the major band corresponds to bovine serum albumin present in the cell culture media. These impurities were removed by affinity chromatography on heparin-Sepharose (see Experimental Procedures). Enterokinase digestion of the purified fusion protein gave a reduction in size to ∼32 kDa (Fig. 1A, lane 2) . The predicted molecular mass of rMCP-5 is 25.392 Da. However, the protein primary sequence contains one potential glycosylation site, and it is thus possible that carbohydrate addition may explain the migration pattern.
Binding of the inhibitor diisopropylfluorophosphate (DFP)
The serine protease inhibitor DFP binds covalently to catalytically active serine proteases only, and can therefore be used to determine if a protease is functional or not.
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of other 3 H-labeled proteins demonstrates the absence of contaminating serine proteases.
P1 specificity of rMCP-5
The cleavage specificity of rMCP-5 was examined by using chromogenic substrates of the general structure Suc-Ala-Ala-Pro-X-pNA, where X (the P1 position) was a
Val, Ala, Ile, Leu or a Phe residue ( Table I ). The k cat and K m values were relatively similar for substrates containing Val, Ile or Ala at the P1 position. In contrast, the corresponding substrate with a Phe at the P1 position was cleaved at very low rate, and it was therefore not possible to determine the k cat or K m value for this substrate.
Similarly, the cleavage rate for the substrate with a P1 Leu was too low to allow determination of kinetic constants. Although it was not possible to determine k cat or K m values for the substrates with Leu or Phe at the P1 position, some hydrolysis of these substrates was observed at a high concentration of substrate (3.5 mM) (Table I) .
At lower substrate concentrations (e.g. 0.36 mM; Table I ), the hydrolysis of the latter substrates was below the level of detection. Taken together, these results indicate that the cleavage specificity of rMCP-5 is elastase-rather than chymotrypsin-like.
The effect of heparin on inhibition of rMCP-5 by α 1 -antitrypsin (α 1 -AT)
To further establish the elastase-like substrate specificity, and to study the sensitivity of rMCP-5 towards inhibitors, rMCP-5 was incubated with the serpin α 1 -AT, an inhibitor that is well known for its effective inhibition of neutrophil elastase. The reactive center loop located in the C-terminal of the serpin contains the P1-P1' residues, which, when cleaved by the protease, undergoes a conformational change which ultimately traps the protease in a locking conformation (24) . As shown in .
Determination of cleavage specificity by phage-displayed nonapeptides
To further characterize the substrate specificity of recombinant rMCP-5, a library of nonameric peptides were screened for their sensitivity for cleavage by rMCP-5. DNA oligonucleotides encoding the randomized peptides, followed by a His 6 -tag, were ligated into the T7 phage gene encoding the capsid protein 10. Phages were attached to a Ni-NTA agarose resin by their His 6 tag, and exposed to active rMCP-5 over
night. An aliquot of the phages that were released by the treatment with rMCP-5 was plated in top agarose to determine the amount of phages released during each 13 selection (Fig. 3) . The amount of released phages, relative to the control (phages incubated w/o rMCP-5), increased with each selection thus verifying a higher number of rMCP-5-susceptible phages after each round of selection. After five rounds of selection, 40 individual clones were subjected to DNA sequencing. The obtained sequences corresponding to the substrate regions were aligned (see below) and are listed in Table II .
It is clear from the experiments using chromogenic substrates that the preferred P1 amino acids for rMCP-5 susceptibility are Val, Ala or Ile (Table I) . Strikingly, all of the rMCP-5-susceptible clones that were sequenced contained either of these amino acids in their substrate region (Table II) , supporting that Val, Ile or Ala may indeed be the preferred P1 residues. In many cases, several of the implicated P1 residues were present in the same clone, e.g. four Val residues in clones 32 and 37, indicating multiple potential P1 residues. Moreover, it is possible that the presence of several P1 may increase the chance of cleavage of a phage, hence their frequent occurrence in the selected library.
The multiple potential P1 residues in most of the clones imposes inherent challenges when aligning the sequences into a P4-P2' consensus. When aligning the sequences, consideration was therefore taken to previous data on subsite specificity for HC (25) .
In a study by Bastos et al (26) with inhibitor peptide libraries, HC was shown to have superior affinity for inhibitors with a P2' Glu or Asp. Hence, when choosing among P1 aa for the alignment of the phage displayed substrates, a combination of a P2' Glu or Asp and a P1 Val, Ala or Ile was favored. In Table II , the sequences of the substrate regions are thus aligned accordingly. Notably, a combination of a P1
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Val/Ala/Ile and a P2' Glu/Asp was found in as much as 50% of the clones. The frequency of a specific amino acid residue in each subsite is shown in Fig. 4 , where the heights of the bars in each diagram represents the occurrence in percent of that amino acid in the subsite. Fig. 4A shows that a number of different amino acids are tolerated in the P4 site. However, Pro or amino acids with small side chains such as Ala, Gly and Val are overrepresented. A more limited specificity is seen in the P3 subsite ( Fig. 4B ) with a strong preference for Leu, Val, Thr or Glu. At the P2 position (Fig. 4C) , rMCP-5 appears to prefer small aliphatic amino acid residues. The highest variation was seen at the P1' position ( Fig. 4E) , where most amino acids seem to be tolerated. It is clear from the alignment that rMCP-5 shows a strong preference for acidic residues at the P2' position (Fig. 4F) .
Discussion
Mast cells are distributed at mucosal and submucosal surfaces where they take part in our defense against invading microbes and large parasites. Upon stimulation with antigen they can rapidly degranulate and release potent mediators. Some of these mediators belong to the serine protease family, e.g. tryptase and chymase. Tryptase and chymase belong to the large chymotrypsin-family of serine proteases. All members of this family share a common structure but have diverse substrate specificity. For example, tryptases cleave a substrate C-terminally of basic amino acids, whereas chymases cleave substrates after aromatic amino acids. The specificity of proteases, i.e. substrate recognition, is dictated by complementarity between the protease substrate cleft and the substrate. Upon alignment of the key residues that form the substrate cleft in serine proteases, a subfamily of α-chymases was identified, where Gly216 is replaced by a Val residue (20) . The members of this family could possibly possess elastase rather than chymase substrate specificity. We have examined rMCP-5, a protease that belongs to this subfamily. The mature form of rMCP-5 bound the serine protease inhibitor DFP, thus verifying that rMCP-5 was active. Further, the catalytic properties of rMCP-5 were shown to be elastase-like, with preference for small, aliphatic P1 amino acids such as Val and Ala. However, in contrast to the HC Gly216Val mutant described by Solivan and coworkers (20) , the activity of rMCP-5 towards substrates with P1 Leu was very low (Table I) . Hence, apart from Val216, other aa may contribute to the exclusion of large P1 residues in rMCP-5.
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Like other mast cell chymases, rMCP-5 is packed in the mast cell secretory granules intimately bound to serglycin proteoglycans (27). Analysis of the surface regions of the mouse orthologue mMCP-5 revealed two distinct regions that may be involved in proteoglycan binding (28) . Interestingly, mMCP-5 protein is not present in mice deprived of an enzyme involved in sulphation of heparin proteoglycan, NDST-2, indicating an essential role for heparin in the processes that lead to proper storage of mMCP-5 (27,29). In addition, heparin has been shown to protect certain rodent β-chymase and HC from inhibition by natural protease inhibitors (30) (31) (32) . Here we show that also rMCP-5 binds to heparin and that the association with heparin protects rMCP-5 from inhibition by α 1 -AT (Fig. 2) . Thus, the binding of rMCP-5 to heparin may have a dual functional significance, regulating both its storage in the secretory granules as well as increasing the active lifetime for rMCP-5 after mast cell degranulation. In addition, the inhibitor seems to be sensitive to proteolytic degradation by rMCP-5 at an additional site, apart from that in the reactive center loop in the inhibitor, since an additional band can be seen at around 33 kDa.
In this paper we show that the rMCP-5 has elastase-rather than chymotrypsin-like cleavage specificity, despite its previous classification as a chymase. During the preparation of this manuscript another paper was published on the specificity of rodent α-chymases (33). The results presented in that article are in agreement with an elastase-like P1 specificity of the rodent α-chymases, although the extended substrate specificities of these proteases were not examined.
Target recognition of a chymase is not only dictated by its primary (P1) specificity. A phage displayed peptide library is a powerful tool to determine the extended (Table II) demonstrated that this protease has a substrate specificity similar to that published previously for HC, apart from the P1 position (25) . However, because P4
Pro, Val and Gly, i.e. the preferred P4 residues for rMCP-5, were excluded in the study on HC specificity, the substrate specificity of HC cannot be compared to that of rMCP-5 directly. Interestingly, Pro has previously been shown by others to be favored in the P4 position for human tryptase (34, 35) . A Pro residue causes a bend in the peptide chain, which may result in a better insertion of the substrate into the substrate pocket. However, for HC a Pro in P2 has been predicted to be of more advantage, since it facilitates the insertion of P1 Phe into the S1 pocket (36) .
At the P3 subsite, rMCP-5 showed preference for aliphatic aa such as Val and Leu (Fig. 4B) . In addition, a number of sequences had the acidic aa Glu in P3, a specificity also shared with HC. However, in contrast to substrate regions recognized by HC and, specifically, rMCP-1 (25), P3 aromatic aa are absent in the rMCP-5-susceptible substrate regions. The same phage library has previously been used successfully to determine the substrate specificity of a rat β-chymase (rMCP-4) with P1 specificity for aromatic aa (23) . All of the sequenced rMCP-4-susceptible clones contained one or several aromatic amino acid residues, demonstrating that the lack of aromatic P3 residues in the rMCP-5-susceptible substrate regions is not a consequence of a limited library. Hence, we predict that a smaller substrate pocket of rMCP-5 might cause this exclusion of large P3 aa.
Another interesting aspect of the extended substrate specificity of rMCP-5 is the preference for substrates with acidic P2' (Fig. 4F) . However, studies on substrate specificities for the β-chymases mMCP-4 (37), rat vascular chymase (38) and hamster chymase-1 (39) revealed heterogeneity of substrate selectivity within this group. For example, rat vascular chymase was the first β-chymase identified as a true selective Ang I converter (38). Further, mMCP-4 was shown to be less degenerative towards Ang I than its rat counterpart (rMCP-1),
cleaving both sites with nearby equal kinetics (37) . The heterogeneity among β-chymases suggests that they are not redundant proteases, but have distinct functions in Table II . Suc-Ala-Ala-Pro-Ala-pNA 0.004 0.037 7.6 0.029 3.8
Suc-Ala-Ala-Pro-Phe-pNA n.d. 
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